Management of Patients on Non–Vitamin K Antagonist Oral Anticoagulants in the Acute Care and Periprocedural Setting
Published: February 06, 2017
- Non-Vitamin K oral anticoagulation (NOAC) is widely used as an alternative to warfarin for stroke prevention in atrial fibrillation and management of venous thromboembolism.
- Data are sparse about how to manage patients on NOACs who are actively bleeding or who are risk for bleeding due to an acute care episode or in the periprocedural setting.
- This scientific statement addresses management of patients in these situations.
- Recommendations for the Management of Clinically significant Drug-Drug Interactions with Statins and Select Agents used in Patients with Cardiovascular Disease
- 2014 AHA/ACC/HRS Guideline for the Management of Patients with Atrial Fibrillation
- 2011 ACCF/AHA/ACAI Guideline for Percutaneous Coronary Intervention
- Guidelines for the Primary Prevention of stroke
- Guidelines for the Prevention of Stroke in Patients with Stroke and Transient Ischemic Attack